Search Results - "McMurray, Ryan P."

Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma by Schoen, Robert E, Boardman, Lisa A, Cruz-Correa, Marcia, Bansal, Ajay, Kastenberg, David, Hur, Chin, Dzubinski, Lynda, Kaufman, Sharon F, Rodriguez, Luz M, Richmond, Ellen, Umar, Asad, Szabo, Eva, Salazar, Andres, McKolanis, John, Beatty, Pamela, Pai, Reetesh K, Singhi, Aatur D, Jacqueline, Camille M, Bao, Riyue, Diergaarde, Brenda, McMurray, Ryan P, Strand, Carrie, Foster, Nathan R, Zahrieh, David M, Limburg, Paul J, Finn, Olivera J

“…To assess whether MUC1 peptide vaccine produces an immune response and prevents subsequent colon adenoma formation. Multicenter, double-blind,…”
Get full text

Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis by Samadder, N Jewel, Foster, Nathan, McMurray, Ryan P, Burke, Carol A, Stoffel, Elena, Kanth, Priyanka, Das, Rohit, Cruz-Correa, Marcia, Vilar, E, Mankaney, Gautam, Buttar, Navtej, Thirumurthi, Selvi, Turgeon, Danielle K, Sossenheimer, Michael, Westover, Michelle, Richmond, Ellen, Umar, Asad, Della'Zanna, Gary, Rodriguez, Luz M, Szabo, Eva, Zahrieh, David, Limburg, Paul J

“…Patients with familial adenomatous polyposis (FAP) are at markedly increased risk for duodenal adenomas and cancer. Combination sulindac and erlotinib was…”
Get more information

Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial by Loprinzi, Charles, Le-Rademacher, Jennifer G., Majithia, Neil, McMurray, Ryan P., O’Neill, Carrie R., Bendel, Markus A., Beutler, Andreas, Lachance, Daniel H., Cheville, Andrea, Strick, David M., Black, David F., Tilburt, Jon C., Smith, Thomas J.

“…Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a prominent clinical problem, with limited effective therapies. Preliminary non-randomized…”
Get full text

Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers by Weinberg, David S., Foster, Nathan R., Della'Zanna, Gary, McMurray, Ryan P., Kraft, Walter K., Pallotto, Angela, Kastenberg, David M., Katz, Leo C., Henry, Christopher H., Moleski, Stephanie M., Limburg, Paul J., Waldman, Scott A.

“…Guanylyl cyclase C (GUCY2C) is a tumor-suppressing receptor silenced by loss of expression of the luminocrine hormones guanylin and uroguanylin early in…”
Get full text

Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial by Porter, Alyx B, Liu, Heshan, Kohli, Sadhna, Cerhan, Jane L, Sloan, Jeff, McMurray, Ryan P, Le-Rademacher, Jennifer, Loprinzi, Charles L, Villano, John L, Kizilbash, Sani H, Mehta, Minesh P, Jaeckle, Kurt A, Brown, Paul D

“…Nearly 96% of patients with high-grade glioma (HGG) report moderate-to-severe fatigue. Armodafinil is a psychostimulant that might help cancer-related fatigue…”
Get more information

Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812) by Maggiore, Ronald J., Zahrieh, David, McMurray, Ryan P., Feliciano, Josephine L., Samson, Pamela, Mohindra, Pranshu, Chen, Hongbin, Wong, Melisa L., Lafky, Jacqueline M., Jatoi, Aminah, Le-Rademacher, Jennifer G.

“…Optimal treatment for older adults with stage III non-small cell lung cancer (NSCLC) remains unclear. Here we hypothesized that sequential chemoradiation…”
Get full text

Abstract 5092: Participant satisfaction with cancer chemoprevention clinical trials: The Mayo Clinic Cancer Prevention Network (CPN) experience by Zahrieh, David, McMurray, Ryan P., Foster, Nathan R., Limburg, Paul J., Mandrekar, Sumithra J.

“…INTRODUCTION Participating in a clinical trial is a personal choice and an individual experience. Several barriers to recruitment of high risk men and women in…”
Get full text